Tandem Diabetes Care Inc (TNDM) - Total Liabilities
Based on the latest financial reports, Tandem Diabetes Care Inc (TNDM) has total liabilities worth $1.02 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Tandem Diabetes Care Inc equity growth rate to track the company's year-over-year net asset growth rate.
Tandem Diabetes Care Inc - Total Liabilities Trend (2011–2025)
This chart illustrates how Tandem Diabetes Care Inc's total liabilities have evolved over time, based on quarterly financial data. See TNDM free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Tandem Diabetes Care Inc Competitors by Total Liabilities
The table below lists competitors of Tandem Diabetes Care Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TotalEnergies EP Gabon S.A.
PA:EC
|
France | €1.30 Billion |
|
Amata Corporation Public Company Limited
BK:AMATA
|
Thailand | ฿39.71 Billion |
|
LAMDA Development S.A.
AT:LAMDA
|
Greece | €3.10 Billion |
|
SK ETERNIX CO LT
KO:475150
|
Korea | ₩1.19 Trillion |
|
Fujian Boss Software Development Co Ltd
SHE:300525
|
China | CN¥1.29 Billion |
|
Jsti Group
SHE:300284
|
China | CN¥6.81 Billion |
|
CATARC Automotive Proving Ground Co.Ltd.
SHE:301215
|
China | CN¥575.08 Million |
|
MYT Netherlands Parent BV
NYSE:MYTE
|
USA | $280.60 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Tandem Diabetes Care Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Tandem Diabetes Care Inc.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.58 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 7.71 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.89 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tandem Diabetes Care Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tandem Diabetes Care Inc (2011–2025)
The table below shows the annual total liabilities of Tandem Diabetes Care Inc from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $725.94 Million | +3.03% |
| 2024-12-31 | $704.56 Million | +10.26% |
| 2023-12-31 | $639.03 Million | +4.27% |
| 2022-12-31 | $612.84 Million | +29.83% |
| 2021-12-31 | $472.02 Million | +34.82% |
| 2020-12-31 | $350.11 Million | +166.99% |
| 2019-12-31 | $131.13 Million | +74.80% |
| 2018-12-31 | $75.02 Million | -39.74% |
| 2017-12-31 | $124.49 Million | +5.22% |
| 2016-12-31 | $118.32 Million | +91.92% |
| 2015-12-31 | $61.65 Million | +18.81% |
| 2014-12-31 | $51.89 Million | +11.17% |
| 2013-12-31 | $46.68 Million | -68.00% |
| 2012-12-31 | $145.87 Million | +71.06% |
| 2011-12-31 | $85.27 Million | -- |
About Tandem Diabetes Care Inc
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and … Read more